Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC) - Episode 6

Lung LCNEC Diagnostic Challenges

,

Panelists discuss the challenges encountered with molecular or pathology testing for lung large cell neuroendocrine carcinoma (LCNEC) and how treatment plans are determined when testing is not feasible.

EP. 1: Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro
EP. 2: An Overview of the Molecular Characterization of Lung LCNEC
EP. 3: The Pathological Diagnosis of Lung LCNEC
EP. 4: Biomarker Testing Strategies for Lung LCNEC
EP. 5: Biopsy Best Practices: Diagnosing Lung LCNEC
Now Viewing
EP. 6: Lung LCNEC Diagnostic Challenges
EP. 7: A Multidisciplinary Approach to Managing Lung LCNEC
EP. 8: Lung LCNEC Disease Histology and Prognosis
EP. 9: The Role of DLL3 in LCNEC of the Lung
EP. 10: Insights on the LANCE Pilot Study on Lung LCNEC
  • Do you encounter challenges with performing molecular or pathology testing?
  • If you are unable to perform testing, how do you determine your treatment plan?

Related Content:

Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC)
Insights on the LANCE Pilot Study on Lung LCNEC
The Role of DLL3 in LCNEC of the Lung
Lung LCNEC Disease Histology and Prognosis